WBC Disorders VIII Flashcards
chimeric BCR-ABL gene
chronic myeloid leukemia - CML
MPD
reciprocal (9;22) (q34;q11) translocation
philadelphia chromosome
90% creates the BCR-ABL gene of CML
BCR - 22
ABL - 9
myeloproliferative disorders
mostly - multipotent progenitor that gives rise to erythrocytes, platelets, granulocytes
less common - pleuripotent giving rise to lymphoid and myeloid clls
CML clinical
adult 50yo
males
fatigue, weak, weight loss, anorexia
abdominal pain/fullness - dragging sensation in abdomen
-due to EMH
LUQ pain - splenic infarct
sea blue histiocytes
scattered macrophage with wrinkled green-blue cytoplasm
in CML
diagnosis of CML
leukocytosis - possibly >100,000
hypercellular bone marrow - granulocytes, eosinos, basos, megas
-sea blue histiocytes and reticulin
LOW LAP**
detection of Ph1 or BCR-ABL fusion gene - chromosomal analysis or PCR based tests
LAP
leukocyte alkaline phosphatase
- low in CML
- high in reactive node - leukamoid rxn
CML prognosis
untreated - slow progression
3 year survival - no tx
50% accelerated phase - blast crisis in 6-12 months
-to AML (majority) or ALL
ikaros mutation
lymphoid blast crisis in CML
Tx of CML
BCR-ABL inhibitor - remission 90%
young pt - HSC transplant
panmyelosis
increased platelets
polycythemia vera
increased red cells, granulocytes, and platelets
RBC increase - polycythemia - most of symptoms
low EPO levels
low EPO, JAK 2 mutation, bone marrow study
polycythemia vera
P. rubra vera
polycythemia vera
PCV
polycythemia vera
clinical for polycythemia vera
late middle age
-insidious onset
pruritis, HA, HTN, GI ulcers, splenomegaly
elevated hematocrit**
bleeding and thrombosis
thrombocytosis >500,000 and many abnormal
DVT, MI, stroke
hyperuricemia - gout
Tx of polycythemia vera
phlebotomy - control RBC mass
-increase life expectancy from months to 10 years
JAK2 inhibitors
spent stage
polycythemia vera
aftet 10 years
fibrosis of marrow - and massive splenomegaly (due to EMH)
no tx with PCV
die from bleeding in months
essential thrombocytosis
increased platelet count
no polycythemia
point mutation in JAK2 or MPL
JAK2 or MPL mutation
essential thrombocytosis
essential thrombocytosis clinical
uncommon
adults > 60yo
insidious onset
high peripheral platelet count
platelets enlarged and abnormal
dx of exclusion - rule out other MPDs
dx of essential thrombocytosis
bone marrow biopsy
-megakaryocyte significant increase
tx of essential thrombocytosis
chemotherapy
essential thrombocytosis prognosis
survival 12-15 yrs
progression to AML uncommon
ET
essential thrombocytosis
erythromelagia
throbbing and burning hands and feet because of small arteriole occlusion and platelet aggregation
with ET
primary myelofibrosis
obliterative marrow fibrosis caused by non-neoplastic fibroblasts
difficult to treat
pt >60yo
PDGF and TGF-beta
fibroblast activators
increased in primary myelofibrosis
JAK2 and MPL mutations
present in primary myelofibrosis
agnogenic myeloid metaplasia
early in progression of primary myelofibrosis
normocytic, normochromic anemia with leukoerythroblastosis on peripheral smear
primary myelofibrosis
primary myelofibrosis prognosis
death 3-5 years
-complications from cytopenias
tx primary myelofibrosis
JAK2 inhibitor
HSC transplant in young
tear drop shaped RBCs
dacrocytes
-damaged from fibrotic marrow
seen in primary myelofibrosis
histiocytoses
macrophages and dendritic cells
S100, CD1a, HLA-DR
positive in langerhans cell histiocytosis
langerhans cell histiocytosis
considered neoplastic
birbeck granules
racket shaped
-vesicular nuclei with linear grooves or folds and vacuolated cytoplasm
in langerhans cell histiocytosis
mutations in BRAF
langerhans cell histiocytosis and hairy cell leukemia
letterer-siwe disease
multifocal/multisystem langerhans cell histiocytosis
seborrheic eruption
skin lesion in multifocal LCH
LCH
langerhans cell histiocytosis
multifocal/multisystem LCH clinical
before age 2
cutaneous lesions, fever, infection, chronic otitis media, mastoiditis
hepatosplenomegaly, lymphadenopathy, pulmonary and bone lesions
multifocal/multisystem LCH prognosis
rapidly fatal
intense chemo - 50% 5 year survival
eosinophilic granuloma
unifocal and multifocal/unisystem LCH
-langerhans cells mixed with eosinos, lymphocytes, plasma cell, neutrophils
unifocal LCH
skeletal system in older children
calvarium, ribs, femur
multifocal unisystem LCH
erosive bony masses in children
diabetes insipidus - pituitary stalk of hypothalamus
diabetes insipidus
multifocal unisystem LCH
hand schuller christain triad
calvarial bone defect
diabetes insipidus
exopthalmos
in multifocal unisystem LCH
tx for multifocal unisytem LCH
chemotherapy
tx for unifocal LCH
local excision - or radiation - cures most
adult smoker
pulmonary LCH
pulmonary LCH
multiple fine nodules and cysts in middle upper long zones
-BRAF mutation - neoplastic
with cigarette smoking**
cessation - may regress**
rare